$QRON
Qrons Inc

2024 Q2 Form 10-K Financial Statement

#000147793224002100 Filed on April 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $57.10K $181.2K
YoY Change -83.29% -58.36%
% of Gross Profit
Research & Development $58.46K $86.67K $462.5K
YoY Change -702.35% -49.26% 137.88%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $79.25K $143.8K $643.7K
YoY Change 238.43% -71.95% 2.23%
Operating Profit -$79.25K -$643.7K
YoY Change 238.43% 2.23%
Interest Expense $13.62K -$34.71K $105.6K
YoY Change -77.06% -66.71% -22.16%
% of Operating Profit
Other Income/Expense, Net -$30.01K -$145.7K
YoY Change -715.4% 40.22%
Pretax Income -$178.5K -$789.4K
YoY Change -71.06% 7.61%
Income Tax
% Of Pretax Income
Net Earnings -$109.3K -$178.5K -$789.3K
YoY Change 757.26% -71.06% 7.61%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01 -$0.06
COMMON SHARES
Basic Shares Outstanding 13.65M shares 13.59M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $420.00 $420.00
YoY Change -86.32% -86.32%
Cash & Equivalents $11.71K $420.00 $420.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $11.71K $420.00 $420.00
YoY Change 76.18% -86.31% -86.32%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $11.71K $420.00 $420.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $11.71K $420.00 $420.00
YoY Change 76.18% -86.31% -86.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $238.7K $238.7K
YoY Change 39.59% 39.59%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $524.5K $524.5K
YoY Change 14.39% 14.39%
Long-Term Debt Due $271.9K $271.9K
YoY Change -7.57% -7.57%
Total Short-Term Liabilities $1.117M $1.324M $1.324M
YoY Change -15.01% 3.23% 3.23%
LONG-TERM LIABILITIES
Long-Term Debt $80.00K $80.00K
YoY Change
Other Long-Term Liabilities $85.00K $85.00K
YoY Change
Total Long-Term Liabilities $122.7K $165.0K $165.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.117M $1.324M $1.324M
Total Long-Term Liabilities $122.7K $165.0K $165.0K
Total Liabilities $1.240M $1.489M $1.489M
YoY Change -5.68% 16.09% 16.09%
SHAREHOLDERS EQUITY
Retained Earnings -$10.48M -$10.32M
YoY Change 8.94% 8.28%
Common Stock $1.395K $1.365K
YoY Change 2.65% 1.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.228M -$1.488M -$1.488M
YoY Change
Total Liabilities & Shareholders Equity $11.71K $420.00 $420.00
YoY Change 76.18% -86.31% -86.32%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$109.3K -$178.5K -$789.3K
YoY Change 757.26% -71.06% 7.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$20.23K -$68.65K
YoY Change 31.36% -34.3%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.50K $66.00K
YoY Change 35.0% -8.97%
NET CHANGE
Cash From Operating Activities -20.23K -$68.65K
Cash From Investing Activities 0.000 $0.00
Cash From Financing Activities 13.50K $66.00K
Net Change In Cash -6.730K -$2.649K
YoY Change 24.63% -91.72%
FREE CASH FLOW
Cash From Operating Activities -$20.23K -$68.65K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-22679 usd
CY2023 us-gaap Fiscal Period
FiscalPeriod
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Fiscal year end:</em> The Company has selected December 31 as its fiscal year end.</p>
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><em>Use of Estimates:</em> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported therein. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be based upon amounts that differ from these estimates.</p>
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
462459 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194406 usd
CY2023 qron Fair Value Assumption Expected Dividend Convertible Note Rate
FairValueAssumptionExpectedDividendConvertibleNoteRate
0 pure
CY2022 qron Fair Value Assumption Risk Free Interest Convertible Note Rate
FairValueAssumptionRiskFreeInterestConvertibleNoteRate
0.0441 pure
CY2023 qron Fair Value Assumption Risk Free Interest Convertible Note Rate
FairValueAssumptionRiskFreeInterestConvertibleNoteRate
0.0423 pure
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6334536 shares
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
66000 usd
CY2022Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
124200 usd
CY2022Q2 qron Accrued Interest Outstanding
AccruedInterestOutstanding
186300 usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
150000 usd
CY2021Q4 qron Derivative Liabilities Convertible Note Current
DerivativeLiabilitiesConvertibleNoteCurrent
157490 usd
CY2022 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
-100457 usd
CY2022Q4 qron Derivative Liabilities Convertible Note Current
DerivativeLiabilitiesConvertibleNoteCurrent
57033 usd
CY2023 us-gaap Fair Value Option Changes In Fair Value Gain Loss1
FairValueOptionChangesInFairValueGainLoss1
27965 usd
CY2023Q4 qron Derivative Liabilities Convertible Note Current
DerivativeLiabilitiesConvertibleNoteCurrent
84998 usd
CY2023 qron Schedule Of Fair Value At Commitment And Remeasurement Dates Derivative Liabilities
ScheduleOfFairValueAtCommitmentAndRemeasurementDatesDerivativeLiabilities
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Commitment</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Date</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Expected dividends</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Expected volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">154%-173</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">% </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">194.20%-201.98</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">% </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">170.40%-224.62</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">% </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Expected term</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">2.10 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">1.08 - 1.22 years</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">2.08 – 2.22 years </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Risk free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.42-1.65</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">% </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.41</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">%</p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.23</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">%</p></td></tr></tbody></table>
CY2022Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
76350 usd
CY2023Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
162000 usd
CY2023Q2 qron Accrued Interest Outstanding
AccruedInterestOutstanding
243000 usd
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
150000 usd
CY2023Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
52500 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
35091 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
55655 usd
CY2023 us-gaap Loss On Contract Termination For Default
LossOnContractTerminationForDefault
38000 usd
CY2022 us-gaap Loss On Contract Termination For Default
LossOnContractTerminationForDefault
62100 usd
CY2023 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
19934 usd
CY2022 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
4973 usd
CY2023Q2 us-gaap Stock Issued1
StockIssued1
52500 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2099 usd
CY2023Q2 qron Derivative Liability Associated With Warrants
DerivativeLiabilityAssociatedWithWarrants
2012 usd
CY2023Q2 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
33932 usd
CY2019Q2 us-gaap Commercial Paper
CommercialPaper
100000 usd
qron Description Of Fund
DescriptionOfFund
Qrons is tasked with raising $2 million funds to support Tellurium Research. If within a year after the commencement of the Agreement, Qrons fails to raise at least $2 million, the license will be terminated unless agreed otherwise by the parties
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
800000 shares
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13649789 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13439789 shares
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
115000 shares
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.00
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001689084
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13649789 shares
CY2023 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2023Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08 pure
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55800
CY2023 dei Entity Registrant Name
EntityRegistrantName
QRONS INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3623646
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
28-10 Jackson Avenue #26N
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Long Island City
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11101
CY2023 dei City Area Code
CityAreaCode
212
CY2023 dei Local Phone Number
LocalPhoneNumber
945-2080
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1327916 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13649789 shares
CY2023 dei Auditor Name
AuditorName
Green Growth CPAS
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2023 dei Auditor Firm
AuditorFirmId
6580
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
420 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3069 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
420 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3069 usd
CY2023Q4 us-gaap Assets
Assets
420 usd
CY2022Q4 us-gaap Assets
Assets
3069 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
155357 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
128285 usd
CY2023Q4 qron Due To Related Party Currents
DueToRelatedPartyCurrents
83291 usd
CY2022Q4 qron Due To Related Party Currents
DueToRelatedPartyCurrents
42671 usd
CY2023Q4 qron Due To Other Related Party Classified Current
DueToOtherRelatedPartyClassifiedCurrent
85873 usd
CY2022Q4 qron Due To Other Related Party Classified Current
DueToOtherRelatedPartyClassifiedCurrent
85873 usd
CY2023Q4 qron Advances From Related Party
AdvancesFromRelatedParty
424500 usd
CY2022Q4 qron Advances From Related Party
AdvancesFromRelatedParty
358500 usd
CY2023Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
100000 usd
CY2022Q4 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
100000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
185974 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
208247 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
288720 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
358775 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1323715 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1282351 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
80000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
84998 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
164998 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1488713 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1282351 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2000 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
2 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
2 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13649789 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13439789 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1365 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1344 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8834631 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8254316 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10324291 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9534944 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1488293 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1279282 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
420 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3069 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
462459 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
194406 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
70946 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
70199 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110272 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
365024 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
643677 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
629629 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-643677 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-629629 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-33932 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Interest Expense
InterestExpense
105589 usd
CY2022 us-gaap Interest Expense
InterestExpense
135654 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-6149 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
31766 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-145670 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-103888 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-789347 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-733517 usd
CY2023 qron Net Loss Per Common Shares Basic And Diluted
NetLossPerCommonSharesBasicAndDiluted
-0.06
CY2022 qron Net Loss Per Common Shares Basic And Diluted
NetLossPerCommonSharesBasicAndDiluted
-0.06
CY2023 qron Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
13528310 shares
CY2022 qron Weighted Average Shares Outstanding Basic And Diluted
WeightedAverageSharesOutstandingBasicAndDiluted
13299652 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1102745 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
76350 usd
CY2022 qron Stock Options Granted To Officers
StockOptionsGrantedToOfficers
320420 usd
CY2022 qron Issued During Period Value Options Granted To Non Employee
IssuedDuringPeriodValueOptionsGrantedToNonEmployee
160210 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-733517 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1279282 usd
CY2023 qron Issuance Of Common Stock To Noteholder Amount
IssuanceOfCommonStockToNoteholderAmount
52500 usd
CY2023 qron Stock Award Amount
StockAwardAmount
16680 usd
CY2023 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
45811 usd
CY2023 qron Issued During Period Value Options Granted To Non Employee
IssuedDuringPeriodValueOptionsGrantedToNonEmployee
465345 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-789347 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1488293 usd
CY2023 us-gaap Profit Loss
ProfitLoss
789347 usd
CY2022 us-gaap Profit Loss
ProfitLoss
733517 usd
CY2023 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
465345 usd
CY2022 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
160210 usd
CY2023 qron Stock Issued During Period Value Issued For Consulting Services
StockIssuedDuringPeriodValueIssuedForConsultingServices
45811 usd
CY2022 qron Stock Issued During Period Value Issued For Consulting Services
StockIssuedDuringPeriodValueIssuedForConsultingServices
0 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
0 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
320420 usd
CY2023 qron Stock Award Issued Value
StockAwardIssuedValue
16680 usd
CY2022 qron Stock Award Issued Value
StockAwardIssuedValue
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-33932 usd
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Noninterest Expense
NoninterestExpense
38000 usd
CY2022 us-gaap Noninterest Expense
NoninterestExpense
62100 usd
CY2023 qron Accretion Of Debt Discount Premium
AccretionOfDebtDiscountPremium
35091 usd
CY2022 qron Accretion Of Debt Discount Premium
AccretionOfDebtDiscountPremium
56196 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-6149 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
31766 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
39070 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
46509 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
40620 usd
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
15352 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68649 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-104496 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
66000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
72500 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
66000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
72500 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2649 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-31996 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3069 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35065 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
420 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3069 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 qron Common Stock Issued Under Notes Amended
CommonStockIssuedUnderNotesAmended
52500 usd
CY2022 qron Common Stock Issued Under Notes Amended
CommonStockIssuedUnderNotesAmended
76350 usd
CY2023 qron Debt Discount From Amended Convertible Note
DebtDiscountFromAmendedConvertibleNote
29461 usd
CY2022 qron Debt Discount From Amended Convertible Note
DebtDiscountFromAmendedConvertibleNote
24634 usd
CY2023 qron Accrued Interest Payable Modified Upon Note Amendment
AccruedInterestPayableModifiedUponNoteAmendment
12000 usd
CY2022 qron Accrued Interest Payable Modified Upon Note Amendment
AccruedInterestPayableModifiedUponNoteAmendment
9200 usd
CY2023 qron Convertible Notes Related Party Modified To Six Promissory Note
ConvertibleNotesRelatedPartyModifiedToSixPromissoryNote
0 usd
CY2022 qron Convertible Notes Related Party Modified To Six Promissory Note
ConvertibleNotesRelatedPartyModifiedToSixPromissoryNote
25000 usd
CY2023 qron Accrued Interest Payable Related Party Modified To Six Promissory Note
AccruedInterestPayableRelatedPartyModifiedToSixPromissoryNote
0 usd
CY2022 qron Accrued Interest Payable Related Party Modified To Six Promissory Note
AccruedInterestPayableRelatedPartyModifiedToSixPromissoryNote
10873 usd
CY2023 qron Derivative Liability Associated With Warrants
DerivativeLiabilityAssociatedWithWarrants
2012 usd
CY2022 qron Derivative Liability Associated With Warrants
DerivativeLiabilityAssociatedWithWarrants
15416 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
72500 usd
CY2023 qron Schedule Of Convertible Notes Derivative Liabilities
ScheduleOfConvertibleNotesDerivativeLiabilities
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Face value of certain convertible notes, long term</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">80,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">80,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Carrying value, long term</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">80,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">80,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023 qron Schedule Of Fair Value Of Conversion Feature Derivative Liabilities
ScheduleOfFairValueOfConversionFeatureDerivativeLiabilities
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">157,490</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Change in fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(100,457 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Balance at December 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">57,033</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Change in fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">27,965</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Balance at December 31, 2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">84,998</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022 qron Fair Value Assumption Expected Dividend Convertible Note Rate
FairValueAssumptionExpectedDividendConvertibleNoteRate
0 pure
CY2022Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2027-06-15
CY2023Q2 us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2028-06-15
CY2023 qron Schedule Of Convertible Notes Interest Expense Warrants
ScheduleOfConvertibleNotesInterestExpenseWarrants
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>Years ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Amortization of debt discount</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">35,091</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">55,655</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Default interest</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">38,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">62,100</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Interest on the convertible notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">19,934</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,973</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">93,025</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">122,728</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023 us-gaap Interest Expense Debt
InterestExpenseDebt
93025 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
122728 usd
CY2022Q3 qron Principal Amount Related Party Convertible Note Modified To6 Promissory Note
PrincipalAmountRelatedPartyConvertibleNoteModifiedTo6PromissoryNote
35873 usd
CY2022Q3 qron Aggregate Principal Amount
AggregatePrincipalAmount
25000 usd
CY2022Q3 qron Accrued Interest Payable Related Party Convertible Note Modified To6 Promissory Note1
AccruedInterestPayableRelatedPartyConvertibleNoteModifiedTo6PromissoryNote1
10873 usd
CY2023 us-gaap Interest Expense Commercial Paper
InterestExpenseCommercialPaper
2152 usd
CY2022 us-gaap Interest Expense Commercial Paper
InterestExpenseCommercialPaper
560 usd
CY2023Q4 qron Due To Related Party Current
DueToRelatedPartyCurrent
21397 usd
CY2022Q4 qron Due To Related Party Current
DueToRelatedPartyCurrent
15234 usd
CY2023Q2 us-gaap Taxes And Licenses
TaxesAndLicenses
25000 usd
CY2023 qron Licence Expense
LicenceExpense
25000 usd
CY2023 us-gaap Sale Of Stock Percentage Of Ownership After Transaction
SaleOfStockPercentageOfOwnershipAfterTransaction
0.02 pure
CY2023 qron Annual Minimum Royalty Payment Description
AnnualMinimumRoyaltyPaymentDescription
beginning in the first calendar year after the first commercial sale, an annual minimum royalty payment of $500,000, $1,000,000 in the second calendar year, and $2,000,000 in the third calendar year and each year thereafter
CY2023 qron Other Research And Development Expenses
OtherResearchAndDevelopmentExpenses
1000000 usd
CY2023 qron Annual Net Sales
AnnualNetSales
50000000 usd
CY2023Q4 us-gaap Reinsurance Recoverables On Unpaid Losses Allowance
ReinsuranceRecoverablesOnUnpaidLossesAllowance
50000 usd
CY2023Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
4877 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
480630 usd
CY2023Q4 qron Unrecognized Compensation
UnrecognizedCompensation
220916 usd
CY2022Q4 qron Unrecognized Compensation
UnrecognizedCompensation
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001

Files In Submission

Name View Source Status
R42.htm Edgar Link pending
0001477932-24-002100-index-headers.html Edgar Link pending
0001477932-24-002100-index.html Edgar Link pending
0001477932-24-002100.txt Edgar Link pending
0001477932-24-002100-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
qron-20231231.xsd Edgar Link pending
qron_10k.htm Edgar Link pending
qron_10kimg2.jpg Edgar Link pending
qron_10kimg3.jpg Edgar Link pending
qron_ex31.htm Edgar Link pending
qron_ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
qron-20231231_cal.xml Edgar Link unprocessable
qron-20231231_def.xml Edgar Link unprocessable
qron-20231231_lab.xml Edgar Link unprocessable
qron-20231231_pre.xml Edgar Link unprocessable
qron_10k_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable